Deniz Kural is a serial founder and scientist with 14 years of experience building bioinformatics and biotech companies from Cambridge, MA. He co-founded Seven Bridges and later Totient (acquired by Absci), combining deep domain expertise from a PhD in Biology with a BA in Mathematics to translate research-grade biology into scalable products. As CEO and founder across multiple ventures and now leading mechanica, he blends hands-on technical leadership with strategy, fundraising, and product execution. His background includes hands-on laboratory work at Harvard Medical School and research at Harvard Law School’s Berkman Center, reflecting a rare mix of wet-lab, computational, and policy-adjacent experience. Known for bridging science and engineering, he focuses on making complex bioinformatics workflows practical for industry use. Colleagues describe him as an entrepreneurial scientist who regularly moves between code, lab, and the boardroom to drive measurable impact.
14 years of coding experience
6 years of employment as a software developer
Bachelor of Arts - BA Mathematics, Bachelor of Arts - BA Mathematics at Harvard University
Doctor of Philosophy (PhD) Biology (Specialization in Bioinformatics), Doctor of Philosophy (PhD) Biology (Specialization in Bioinformatics) at Boston College
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.